EVOTEC INTERNATIONAL GMBH -  

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:> 1000
2019
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:> 1000

Ranking timeline:

Project Participation Performance(2019-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 3
As coordinator: 0
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 0 89.815.600 0 1
2019 0 20.299.995 0 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE2
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V2
GRITSYSTEMS AS2
JANSSEN PHARMACEUTICA NV2
UPPSALA UNIVERSITET2
ASCLEPIA OUTSOURCING SOLUTIONS BVBA1
BEAM ALLIANCE1
BILL & MELINDA GATES FOUNDATION1
BIOCOM1
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL1
CENTRE D'ETUDE ET DE RECHERCHES VETERINAIRES ET AGROCHIMIQUES1
COMMISSARIAT A L'ENERGIE ATOMIQUE1
CONSIGLIO NAZIONALE DELLE RICERCHE1
CRITICAL PATH INSTITUTE LIMITED1
DEPARTMENT OF HEALTH1
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
FONDATION INNOVATIVE MEDICINES FOR TUBERCULOSIS (IM4TB)1
FORSCHUNGSZENTRUM BORSTEL1
FUNDACIO PRIVADA INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I SANT PAU1
FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSIATRIO LA PAZ1
GLAXOSMITHKLINE INVESTIGACION Y DESARROLLO SL1
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT1
GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT NON PROFIT ORGANISATION1
HELMHOLTZZENTRUM FUR INFEKTIONSFORSCHUNG1
IMABIOTECH SAS1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE1
INSTITUT PASTEUR1
INSTITUT PASTEUR DE LILLE1
KLINIKUM DER UNIVERSITAET ZU KOELN1
LATVIAN INSTITUTE OF ORGANIC SYNTHESIS1
LUND UNIVERSITY1
MEDIZINISCHE UNIVERSITAET WIEN1
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE1
NORTH BRISTOL NATIONAL HEALTH SERVICE TRUST1
NOSOPHARM1
QPS NETHERLANDS BV1
SERVICIO MADRILENO DE SALUD1
STATENS SERUM INSTITUT1
STICHTING LYGATURE1
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL1
THE UNIVERSITY OF LIVERPOOL1
UNIVERSIDAD CARLOS III DE MADRID1
UNIVERSIDAD DE ZARAGOZA1
UNIVERSITA DEGLI STUDI DI PADOVA1
UNIVERSITA DEGLI STUDI DI PAVIA1
UNIVERSITY OF DUNDEE1

Constancy:

Total number of partners: 52
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 52
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2020-01-01EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS ERA4TBparticipant89.815.60033
2019-11-01Collaboration for Prevention and Treatment of MDR Bacterial Infections COMBINEparticipant8.000.00011
2019-07-01NOVEL GRAM-NEGATIVE ANTIBIOTIC NOW GNA NOWparticipant12.299.99511